SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation
Émile LacasseiD, Isabelle DubuciD, Joannie LeclerciD, Annie GraveliD, Leslie Gudimard, Charles Joly-BeauparlantiD, Marion Faure, Patrick Fortin, Marie‐Renée BlanchetiD, Arnaud DroitiD, Louis FlamandiD
Abstract
Despite the end of the COVID-19 pandemic, SARS-CoV-2 continues to circulate endemically, highlighting the need to better understand the viral determinants of pathogenesis. Non-structural protein 2 (Nsp2) has been implicated in host-virus interactions, yet its function remains poorly defined in the context of infection. Here, we generated a recombinant SARS-CoV-2 lacking Nsp2 ({Delta}Nsp2) to investigate its role in viral replication and disease. While {Delta}Nsp2 replicated comparably to wild-type virus in vitro and in vivo, its deletion resulted in markedly attenuated disease in K18-hACE2 mice. Wild-type infection induced a strong pro-inflammatory response associated with increased recruitment of monocytes and macrophages, whereas {Delta}Nsp2 infection promoted a more balanced antiviral response characterized by enhanced lymphocyte and NK cell recruitment. This was accompanied by reduced pulmonary and systemic inflammation and distinct transcriptional programs, including downregulation of pathways related to RNA processing and translation. Mechanistically, CLIP-seq and proximity labeling suggest that Nsp2 interacts with host RNA and components of the translational machinery. Together, our findings identify Nsp2 as a key virulence factor that drives immunopathology by skewing host immune responses, highlighting its role as a regulator of host-pathogen interactions. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=98 SRC="FIGDIR/small/723222v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@540e40org.highwire.dtl.DTLVardef@73c663org.highwire.dtl.DTLVardef@e5c535org.highwire.dtl.DTLVardef@f62d7f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutations in SARS-CoV-2 Nsp1 are critical determinants of viral pathogenicity in mice
Nathaniel D. Jackson, Fuchun Zhou, … Luis Martínez‐Sobrido·bioRxiv·Aug 19, 2026
- SARS-CoV-2 type I Interferon modulation by non structural proteins 1 and 2
L. Flamand, E. Lacasse, … E. Boilard·bioRxiv·Jun 9, 2022
- Naturally occurring N-terminal mutations in SARS-CoV-2 nsp1 impact innate immune modulation but do not affect virus virulence
Ruchi Rani, Mohammed Nooruzzaman, … Diego G. Diel·bioRxiv·Nov 23, 2024
- Parsing the role of NSP1 in SARS-CoV-2 infection
T. Fisher, A. Gluck, … N. Stern-Ginossar·bioRxiv·Mar 14, 2022
- SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression
P. Naeli, X. Zhang, … S. M. Jafarnejad·bioRxiv·Jan 1, 2023
- SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation
T.-W. Li, A. D. Kenney, … J. Zhu·bioRxiv·May 26, 2021